| Host: | HEK293 cells NA |
| Note: | STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description : | Recombinant-SARS COV2 Spike protein S B.1.1.529 (omicron) Trimer-protein was developed from hek293 cells na na. For use in research applications. |
| Conjugation: | Unconjugated |
| Formulation: | Lyophilised from 0.2 µm filtered PBS pH7.4. NA |
| Dilution Range: | A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers. NA |
| Storage Instruction: | The lyophilized protein is stable for at least 2 years from date of receipt at-20°C C. NA |
| Endotoxin: | Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg (1EU/µg). NA |
| Accession Number: | QIC53204.1 |
| Immunogen: | DNA sequence encoding the COVID-19 Spike S protein [accession# QIC53204.1] variant (B.1.1.529/Omicron) (A67V, del69-70, T95I, del142-144, Y145D, del211, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G4 |
